Middle East Africa Self Blood Glucose Monitoring Market: Market Size & Forecast 2026

The self blood glucose monitoring segment covers finger-stick testing devices and corresponding consumables such as test strips used by diabetic patients for routine glucose measurement outside clinical settings. Market sizing varies slightly across tracking firms, but current estimates place the Middle East and Africa market at approximately USD 267.78 million in 2025, with projections extending through 2031 to 2034. The region is positioned alongside a larger total blood glucose monitoring industry that also includes continuous glucose monitoring devices, which represent a separately tracked and faster-growing segment.

• •Market valued at approximately USD 267.78 million in 2025, equivalent to roughly USD 0.27 billion
• •Projected CAGR of 5.71 to 5.79 percent through 2031 to 2032 across major tracking metrics
• •Government health agencies in the region publish diabetes prevalence and licensing data, though most market-size figures come from private research firms rather than official statistical releases

Rising prevalence of diabetes mellitus across the Middle East and Africa remains the primary engine of demand, driven by urbanization, dietary shifts, and aging populations in countries such as Saudi Arabia, the United Arab Emirates, Egypt, and South Africa. Expanding healthcare access and insurance coverage in the Gulf states has improved patient ability to obtain monitoring devices and test strips regularly. Meanwhile, greater public and clinical awareness of the importance of regular glucose tracking for diabetes management has boosted adoption of self-monitoring solutions in both urban centers and emerging healthcare markets.

• •Increasing diabetes burden in high-prevalence countries including Saudi Arabia, UAE, Egypt, and South Africa
• •Growing healthcare expenditure and insurance coverage for diabetes management products in GCC nations
• •Enhanced clinical and public awareness of preventive glucose monitoring and its role in reducing complications

The market is typically divided into testing devices such as traditional blood glucose meters and the associated consumables, chiefly test strips, with consumables representing the larger recurring revenue stream for manufacturers. Geographically, the Gulf Cooperation Council countries dominate market value due to higher per-capita healthcare spending and stronger distribution networks, while markets in North and Sub-Saharan Africa are expanding from smaller bases as access to diagnostic care improves. The self-monitoring segment runs parallel to the continuous glucose monitoring category, which is valued separately at higher amounts and growing at significantly faster rates.

• •Test strips and consumables form a larger recurring revenue portion compared to meter devices
• •GCC markets hold the highest per-capita value due to advanced healthcare infrastructure and purchasing power
• •North and Sub-Saharan African markets represent emerging opportunities with rising access to diabetes care

What are the recent trends and outlook?

The self blood glucose monitoring segment is expected to sustain steady single-digit growth through the early 2030s as diabetes prevalence continues climbing and more patients gain access to affordable testing solutions. Technological improvements in meter accuracy, connectivity, and ease of use will likely support incremental demand, though the larger adjacent continuous glucose monitoring segment is capturing a growing share of attention and investment. Healthcare policy reforms, greater emphasis on chronic disease management, and expanded insurance coverage for diabetes products will shape the regional trajectory over the forecast horizon.

• •Steady single-digit CAGR expected through 2031 to 2032 based on consistent diabetes prevalence trends
• •Continuous glucose monitoring segment growing at 11.5 to 12.8 percent CAGR, attracting increasing investment attention
• •Regional healthcare reforms and insurance expansion are expected to broaden patient access to monitoring devices